Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $335,105 | 136 | 69.0% |
| Travel and Lodging | $73,109 | 171 | 15.1% |
| Consulting Fee | $49,094 | 14 | 10.1% |
| Food and Beverage | $26,557 | 680 | 5.5% |
| Education | $1,631 | 31 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $125,503 | 163 | $0 (2024) |
| Astellas Pharma US Inc | $108,152 | 181 | $0 (2024) |
| ABBVIE INC. | $90,089 | 147 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $59,679 | 41 | $0 (2022) |
| NeoTract Inc. | $44,346 | 111 | $0 (2020) |
| PFIZER INC. | $20,615 | 65 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $12,256 | 38 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $6,903 | 23 | $0 (2019) |
| Teleflex LLC | $5,599 | 64 | $0 (2024) |
| Lantheus Medical Imaging, Inc. | $2,500 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,304 | 84 | Janssen Biotech, Inc. ($13,375) |
| 2023 | $15,194 | 82 | Janssen Biotech, Inc. ($8,986) |
| 2022 | $85,727 | 135 | Janssen Biotech, Inc. ($61,869) |
| 2021 | $18,070 | 83 | Janssen Biotech, Inc. ($8,568) |
| 2020 | $18,409 | 67 | AbbVie Inc. ($8,425) |
| 2019 | $133,100 | 208 | AbbVie, Inc. ($48,101) |
| 2018 | $112,003 | 200 | Janssen Scientific Affairs, LLC ($37,188) |
| 2017 | $74,688 | 173 | Janssen Scientific Affairs, LLC ($21,733) |
All Payment Transactions
1,032 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| Category: Oncology | ||||||
| 12/07/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $144.59 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | Cash or cash equivalent | $67.00 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | Cash or cash equivalent | $3.00 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| Category: Oncology | ||||||
| 11/14/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $146.47 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| 10/23/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $81.38 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: ONCOLOGY | ||||||
| 09/16/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $33.04 | General |
| 07/31/2024 | Provepharm Inc. | BLUDIGO (Drug) | Consulting Fee | Cash or cash equivalent | $1,310.00 | General |
| Category: MARKER DYE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 987 | 1,212 | $354,184 | $91,842 |
| 2022 | 13 | 720 | 863 | $358,397 | $83,742 |
| 2021 | 12 | 664 | 791 | $260,700 | $76,651 |
| 2020 | 24 | 1,808 | 2,588 | $735,112 | $173,108 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 196 | $58,643 | $16,541 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 166 | 227 | $24,605 | $16,214 | 65.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 134 | 134 | $19,882 | $12,377 | 62.3% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 20 | 20 | $53,413 | $8,611 | 16.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $20,574 | $5,063 | 24.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 70 | 81 | $51,597 | $4,907 | 9.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 33 | $19,602 | $4,439 | 22.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 41 | 48 | $5,436 | $3,701 | 68.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 30 | 30 | $21,460 | $2,778 | 12.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 31 | 37 | $7,178 | $2,496 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 19 | $2,710 | $2,062 | 76.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 33 | 42 | $3,705 | $1,873 | 50.6% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 11 | 11 | $9,494 | $1,819 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 31 | $6,344 | $1,745 | 27.5% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 11 | 41 | $15,271 | $1,636 | 10.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 12 | 12 | $16,810 | $1,354 | 8.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 17 | $3,718 | $1,080 | 29.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 19 | 20 | $2,870 | $998.16 | 34.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 26 | 28 | $5,178 | $881.58 | 17.0% |
| 51702 | Simple insertion of temporary bladder tube | Facility | 2023 | 13 | 30 | $1,732 | $538.65 | 31.1% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 20 | 20 | $1,132 | $437.35 | 38.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 68 | 70 | $2,000 | $228.95 | 11.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 11 | 11 | $830.00 | $61.23 | 7.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 120 | 120 | $19,290 | $11,969 | 62.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 129 | $41,734 | $11,813 | 28.3% |
About Dr. Liam Hurley, MD
Dr. Liam Hurley, MD is a Urology healthcare provider based in North Andover, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093765992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Liam Hurley, MD has received a total of $485,496 in payments from pharmaceutical and medical device companies, with $28,304 received in 2024. These payments were reported across 1,032 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($335,105).
As a Medicare-enrolled provider, Hurley has provided services to 4,179 Medicare beneficiaries, totaling 5,454 services with total Medicare billing of $425,343. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location North Andover, MA
- Active Since 05/11/2006
- Last Updated 09/24/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1093765992
Products in Payments
- ERLEADA (Drug) $93,103
- Erleada (Drug) $69,207
- XTANDI (Drug) $58,860
- Lupron Depot (Drug) $48,101
- Xtandi (Drug) $35,638
- UROLIFT (Device) $25,055
- DARZALEX (Biological) $21,733
- Urolift - UL400 (Device) $20,127
- Lupron (Drug) $19,729
- LUPRON DEPOT (Drug) $16,428
- FIRMAGON (Drug) $6,886
- Xofigo (Drug) $6,363
- Nubeqa (Drug) $5,811
- CREON (Drug) $3,600
- UroLift (Device) $2,650
- UroLift System (Device) $1,841
- INTERSTIM (Device) $1,401
- TOVIAZ (Drug) $1,329
- BLUDIGO (Drug) $1,310
- Axumin (Drug) $1,171
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in North Andover
Dr. George Canellakis, M.d, M.D
Urology — Payments: $8,088
Dr. Steven Previte, M.d, M.D
Urology — Payments: $7,095
Dr. Christopher Ip, M.d, M.D
Urology — Payments: $6,139
Teodora Kurteva, Md, MD
Urology — Payments: $2,449
Dr. Ossama Sakr, M.d, M.D
Urology — Payments: $1,057
Dr. Charles Burke, M.d, M.D
Urology